Company Filing History:
1 out of 1,586 
1 out of 3,539 
Years Active: 2024
Title: The Innovative Contributions of Jeffrey Szymanski
Introduction
Jeffrey Szymanski is a notable inventor based in St. Louis, MO (US). He has made significant strides in the field of medical technology, particularly in cancer detection. His work focuses on improving the lives of patients with neurofibromatosis type 1.
Latest Patents
One of his key patents is for a liquid biopsy method designed to detect cancer early and sensitively in patients with neurofibromatosis type 1. This innovative approach provides new avenues for early diagnosis and treatment, potentially improving patient outcomes.
Career Highlights
Throughout his career, Szymanski has been associated with prestigious institutions such as Washington University and the National Institutes of Health. His work in these organizations has contributed to advancements in medical research and technology.
Collaborations
Some of his notable coworkers include Aadel Chaudhuri and Paul Jones. Their collaborative efforts have further enhanced the impact of Szymanski's research and innovations.
Conclusion
Jeffrey Szymanski's contributions to cancer detection technology exemplify the importance of innovation in healthcare. His work continues to pave the way for better diagnostic methods and improved patient care.